salubrisbio, located in maryland, usa, is a subsidiary of salubris pharmaceuticals co., ltd. the team at salubrisbio is led by prominent and credentialed scientists with experience of discovering new biological molecules. the team is focused on the discovery of novel, biological molecules with global ip protection. salubrisbio endeavor to realize the research from biosimilar to innovation, and from submission in china to synchronized submission in china, usa and eu.
more
splendris pharmaceuticals gmbh, is a registered pharmaceutical manufacturing company based in hessen, germany. the main business of the company is to import, licensing-in and licensing-out medicines for eu market, covering cardiovascular, anti-infective, and oncology therapy. the company also export medicine to the markets outside europe.
more
genekey, a subsidiary company of salubris located in chengdu, china, is focused on research and development of biotechnologically innovative drugs, with r&d platforms for recombinant protein drugs, antibody-based drugs and gene therapy drugs. it possesses a complete industrial chain for innovative drugs including new molecule design, process development, quality research, clinical trials and industrial production.
more
genemen, a stock-holding company is mainly engaged in industrial development of biotechnological drugs. it has built the suzhou engineering technology research center for recombinant protein medicine, which produces products like recombinant protein drugs and monoclonal antibody, covering the therapy of oncology, tissue regeneration, gastroenterology, immunology, etc. core team members are experienced in biological product development for more than 20 years, and they have received several prestigious awards.
more
alain, a subsidiary of salubris, is specialized in r&d and manufacture of both active and passive high-value vascular implants and medical devices.
more
keyidun is a joint stock company of salubris, mainly engaged in r&d, application and promotion of nickel-titanium medical devices.
more